Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 212-224

  Mccann, Mark J ^a   Rowland, Ian R ^b   Roy, Nicole C ^a,c  

^a AGRESEARCH GRASSLANDS   (New Zealand)

^b UNIVERSITY OF READING   (United Kingdom)

^c MASSEY UNIVERSITY   (New Zealand)

Author keywords

DNA replication; Enterolactone; Geminin; Lignan; Prostate

Indexed keywords

2,3 BIS(3' HYDROXYBENZYL)BUTYROLACTONE; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; LIGNAN;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DNA REPLICATION; DRUG EFFECT; HUMAN; MALE; MITOCHONDRION; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

4-BUTYROLACTONE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DNA REPLICATION; HUMANS; LIGNANS; MALE; MITOCHONDRIA; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

MAMMALIA;

EID: 84872827948     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200362     Document Type: Article

References (93)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D. et al., GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Prostate Cancer Incidence, Mortality and Prevalence Worldwide in 2008 Summary Factsheet, International Agency for Research on Cancer, Lyon, France 2010. Available from: http://globocan.iarc.fr/factsheet.asp, accessed on 15/July/2012.
2. World Cancer Research Fund/American Institute for Cancer Research, Food and Drinks. Food, Nutrition, and the Prevention of Cancer: A Global Perspective, AICR, Washington DC, USA 2007, pp. 66-197.
3. Yuan, Y., Ferguson, L. R., Nutrigenetics and prostate cancer: 2011 and beyond. J. Nutrigenet. Nutrigenomics 2011, 4, 121-136.
4. Langeberg, W. J., Isaacs, W. B., Stanford, J. L., Genetic etiology of hereditary prostate cancer. Front Biosci. 2007, 12, 4101-4110.
5. Hsing, A. W., Chokkalingam, A. P., Prostate cancer epidemiology. Front Biosci. 2006, 11, 1388-1413.
6. Kheirandish, P., Chinegwundoh, F., Ethnic differences in prostate cancer. Br. J. Cancer 2011, 105, 481-485.
7. Baade, P. D., Youlden, D. R., Krnjacki, L. J., International epidemiology of prostate cancer: geographical distribution and secular trends. Mol. Nutr. Food Res. 2009, 53, 171-184.
8. Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E. et al., International variation in prostate cancer incidence and mortality rates. Eur. Urol. 2012, 61, 1079-1092.
9. Cullen, J., Elsamanoudi, S., Brassell, S. A., Chen, Y. et al., The burden of prostate cancer in Asian nations. J. Carcinog. 2012, 11, 7.
10. Zhang, L., Yang, B. X., Zhang, H. T., Wang, J. G. et al., Prostate cancer: an emerging threat to the health of aging men in Asia. Asian J. Androl. 2011, 13, 574-578.
11. Adlercreutz, H., Mazur, W., Phyto-oestrogens and Western diseases. Ann. Med. 1997, 29, 95-120.
12. Leitzmann, M. F., Rohrmann, S., Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin. Epidemiol. 2012, 4, 1-11.
13. Hori, S., Butler, E., McLoughlin, J., Prostate cancer and diet: food for thought? BJU Int. 2011, 107, 1348-1359.
14. Schmid, H. P., Fischer, C., Engeler, D. S., Bendhack, M. L. et al., Nutritional aspects of primary prostate cancer prevention. Recent Results Cancer Res. 2011, 188, 101-107.
15. Salem, S., Salahi, M., Mohseni, M., Ahmadi, H. et al., Major dietary factors and prostate cancer risk: a prospective multicentre case-control study. Nutr. Cancer 2011, 63, 21-27.
16. Gonzalez, C. A., Riboli, E., Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur. J. Cancer 2010, 46, 2555-2562.
17. Venkateswaran, V., Klotz, L. H., Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat. Rev. Urol. 2010, 7, 442-453.
18. Khan, N., Afaq, F., Mukhtar, H., Lifestyle as risk factor for cancer: evidence from human studies. Cancer Lett. 2010, 293, 133-143.
19. Muller, D. C., Severi, G., Baglietto, L., Krishnan, K. et al., Dietary patterns and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 3126-3129.
20. McCann, M.J., Gill, C. I., Linton, T., Berrar, D. et al., Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro. Mol. Nutr. Food Res. 2008, 52, 567-580.
21. Chen, L. H., Fang, J., Li, H., Demark-Wahnefried, W. et al., Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol. Cancer Ther. 2007, 6, 2581-2590.
22. Bylund, A., Saarinen, N., Zhang, J. X., Bergh, A. et al., Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp. Biol. Med. 2005, 230, 217-223.
23. Dalais, F. S., Meliala, A., Wattanapenpaiboon, N., Frydenberg, M. et al., Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 2004, 64, 510-515.
24. Bylund, A., Lundin, E., Zhang, J. X., Nordin, A. et al., Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur. J. Cancer Prev. 2003, 12, 407-415.
25. Dabrosin, C., Chen, J., Wang, L., Thompson, L. U., Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 2002, 185, 31-37.
26. Lin, X., Gingrich, J. R., Bao, W., Li, J. et al., Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 2002, 60, 919-924.
27. Demark-Wahnefried, W., Price, D. T., Polascik, T. J., Robertson, C. N. et al., Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2001, 58, 47-52.
28. Lin, X., Swtizer, B. R., Demark-Wahnefried, W., Effect of mammalian lignans on the growth of prostate cancer cell lines. Anti-cancer Res. 2001, 21, 3995-4000.
29. Bylund, A., Zhang, J. X., Bergh, A., Damber, J. E. et al., Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 2000, 42, 304-314.
30. Zhang, J. X., Hallmans, G., Landstrom, M., Bergh, A. et al., Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett. 1997, 114, 313-314.
31. Saarinen, N. M., Tuominen, J., Pylkkänen, L., Santti, R., Assessment of information to substantiate a health claim on the prevention of prostate cancer by lignans. Nutrients 2010, 2, 99-115.
32. Adlercreutz, H., Lignans and human health. Crit. Rev. Clin. Lab Sci. 2007, 44, 483-525.
33. McCann, M.J., Gill, C. I., McGlynn, H., Rowland, I. R., Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr. Cancer 2005, 52, 1-14.
34. Hedelin, M., Klint, A., Chang, E. T., Bellocco, R. et al., Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 2006, 17, 169-180.
35. McCann, S. E., Ambrosone, C. B., Moysich, K. B., Brasure, J. et al., Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr. Cancer 2005, 53, 33-41.
36. Kilkkinen, A., Stumpf, K., Pietinen, P., Valsta, L. M. et al., Determinants of serum enterolactone concentration. Am. J. Clin. Nutr. 2001, 73, 1094-1100.
37. Horner, N. K., Kristal, A. R., Prunty, J., Skor, H. E. et al., Dietary determinants of plasma enterolactone. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 121-126.
38. Vanharanta, M., Voutilainen, S., Rissanen, T. H., Adlercreutz, H. et al., Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch. Intern. Med. 2003, 163, 1099-1104.
39. Woting, A., Clavel, T., Loh, G., Blaut, M., Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol. Ecol. 2010, 72, 507-514.
40. Clavel, T., Henderson, G., Engst, W., Doré, J. et al., Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 2006, 55, 471-478.
41. Clavel, T., Borrmann, D., Braune, A., Doré, J. et al., Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 2006, 12, 140-147.
42. Setchell, K. D. R., Lawson, A. M., Conway, E., Taylor, N. F. et al., The definitive identification of the lignans trans-2, 3-bis(3-hydroxybenzyl)-gamma-butyrolactone and 2, 3-bis(3-hydroxybenzyl) butane-1, 4-diol in human and animal urine. Biochem. J. 1981, 197, 447-458.
43. Stitch, S. R., Toumba, J. K., Groen, M. B., Funke, C. W. et al., Excretion, isolation and structure of a new phenolic constituent of female urine. Nature 1980, 287, 738-740.
44. Setchell, K. D. R., Lawson, A. M., Mitchell, F. L., Adlercreutz, H. et al., Lignans in man and animal species. Nature 1980, 287, 740-743.
45. Setchell, K. D. R., Bull, R., Adlercreutz, H., Steroid excretion during the reproductive cycle and in pregnancy of the vervet monkey (Cercopithecus aethiopus pygerythrus). J. Steroid Biochem. 1980, 12, 375-384.
46. Setchell, K. D. R., Adlercreutz, H., The excretion of two new phenolic compounds (Compound 180/442 and Compound 180/410) during the human menstrual cycle and in pregnancy. J. Steroid Biochem. 1979, 11, xv-xvi.
47. Kuhnle, G. G., Dell'Aquila, C., Aspinall, S. M., Runswick, S. A. et al., Phytoestrogen content of beverages, nuts, seeds, and oils. J. Agric. Food Chem. 2008, 56, 7311-7315.
48. Kuhnle, G. G., Dell'Aquila, C., Aspinall, S. M., Runswick, S. A. et al., Phytoestrogen content of foods of animal origin: dairy products, eggs, meat, fish, and seafood. J. Agric. Food Chem. 2008, 56, 10099-10104.
49. Kiely, M., Faughnan, M., Wähälä, K., Brants, H. et al., Phyto-oestrogen levels in foods: the design and construction of the VENUS database. Br. J. Nutr. 2003, 89, S19-S23.
50. Fletcher, R. J., Food sources of phyto-oestrogens and their precursors in Europe. Br. J. Nutr. 2003, 89, S39-S43.
51. Nurmi, T., Mursu, J., Peñalvo, J. L., Poulsen, H. E. et al., Dietary intake and urinary excretion of lignans in Finnish men. Br. J. Nutr. 2010, 103, 677-685.
52. Kuhnle, G. G., Ward, H. A., Vogiatzoglou, A., Luben, R. N. et al., Association between dietary phyto-oestrogens and bone density in men and postmenopausal women. Br. J. Nutr. 2011, 106, 1063-1069.
53. Pellegrini, N., Valtueña, S., Ardigò, D., Brighenti, F. et al., Intake of the plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy. Nutr. Metab. Cardiovasc Dis. 2010, 20, 64-71.
54. Milder, I. E., Feskens, E. J., Arts, I. C., Bueno de Mesquita, H. B. et al., Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J. Nutr. 2005, 135, 1202-1207.
55. Kilkkinen, A., Valsta, L. M., Virtamo, J., Stumpf, K. et al., Intake of lignans is associated with serum enterolactone concentration in Finnish men and women. J. Nutr. 2003, 133, 1830-1833.
56. Valsta, L. M., Kilkkinen, A., Mazur, W., Nurmi, T. et al., Phyto-oestrogen database of foods and average intake in Finland. Br. J. Nutr. 2003, 89, S31-S38.
57. Morton, M. S., Chan, P. S., Cheng, C., Blacklock, N. et al., Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997, 32, 122-128.
58. Heald, C. L., Ritchie, M. R., Bolton-Smith, C., Morton, M. S. et al., Phyto-oestrogens and risk of prostate cancer in Scottish men. Br. J. Nutr. 2007, 98, 388-396.
59. Peeters, P. H., Slimani, N., van der Schouw, Y. T., Grace, P. B. et al., Variations in plasma phytoestrogen concentrations in European adults. J. Nutr. 2007, 137, 1294-1300.
60. Luo, J. H., Oncogenic activity of MCM7 transforming cluster. World J. Clin. Oncol. 2011, 2, 120-124.
61. Masai, H., Matsumoto, S., You, Z., Yoshizawa-Sugata, N. et al., Eukaryotic chromosome DNA replication: where, when, and how? Annu. Rev. Biochem. 2010, 79, 89-130.
62. Hook, S. S., Lin, J. J., Dutta, A., Mechanisms to control rereplication and implications for cancer. Curr. Opin. Cell Biol. 2007, 19, 663-671.
63. Lau, E., Tsuji, T., Guo, L., Lu, S. H. et al., The role of pre-replicative complex (pre-RC) components in oncogenesis. Faseb J. 2007, 21, 3786-3794.
64. Montanari, M., Macaluso, M., Cittadini, A., Giordano, A., Role of geminin: from normal control of DNA replication to cancer formation and progression? Cell Death Differ. 2006, 13, 1052-1056.
65. Ren, B., Yu, G., Tseng, G. C., Cieply, K. et al., MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006, 25, 1090-1098.
66. Honeycutt, K. A., Chen, Z., Koster, M. I., Miers, M. et al., Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene 2006, 25, 4027-4032.
67. Gonzalez, M. A., Tachibana, K. E., Laskey, R. A., Coleman, N., Control of DNA replication and its potential clinical exploitation. Nat. Rev. Cancer 2005, 5, 135-141.
68. Xouri, G., Lygerou, Z., Nishitani, H., Pachnis, V. et al., Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. Eur. J. Biochem. 2004, 271, 3368-3378.
69. Arentson, E., Faloon, P., Seo, J., Moon, E. et al., Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 2002, 21, 1150-1158.
70. Martin, M. E., Haourigui, M., Pelissero, C., Benassayag, C. et al., Interactions between phytoestrogens and human sex steroid binding protein. Life Sci. 1996, 58, 429-436.
71. Schöttner, M., Spiteller, G., Ganseer, D., Lignans interfering with 5 alpha-dihydrotestosterone binding to human sex hormone-binding globulin. J. Nat. Prod. 1998, 61, 119-121.
72. Adlercreutz, H., Bannwart, C., Wähälä, K., Mäkelä, T. et al., Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol. 1993, 44, 147-153.
73. Adlercreutz, H., Höckerstedt, K., Bannwart, C., Bloigu, S. et al., Effects of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of oestrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem. 1987, 27, 1135-1144.
74. Garreau, B., Vallette, G., Adlercreutz, H., Wähälä, K. et al., Phytoestrogens: new ligands for rat and human alpha-fetoprotein. Biochim. Biophys. Acta 1991, 1094, 339-345.
75. Brooks, J. D., Thompson, L. U., Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 2005, 94, 461-467.
76. Evans, B. A. J., Griffiths, K., Morton, M. S., Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 1995, 147, 295-302.
77. Adlercreutz, H., Mousavi, Y., Clark, J., Höckerstedt, K. et al., Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 1992, 41, 331-337.
78. Adlercreutz, H., Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 1990, 50, 3-23.
79. Mercier-Bodard, C., Nivet, V., Baulieu, E. E., Effects of hormones on SBP mRNA levels in human cancer cells. J. Steroid Biochem. Mol. Biol. 1991, 40, 777-785.
80. Prasad, K., Antioxidant activity of secoisolariciresinol diglycoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int. J. Angiol. 2000, 9, 220-225.
81. Kitts, D. D., Yuan, Y. V., Wijewickreme, A. N., Thompson, L. U., Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cell Biochem. 1999, 202, 91-100.
82. Niemeyer, H. B., Metzler, M., Differences in the antioxidant activity of plant and mammalian lignans. J. Food Eng. 2003, 56, 255-256.
83. Nicholson, B., Theodorescu, D., Angiogenesis and prostate cancer tumour growth. J. Cell Biochem. 2004, 91, 125-150.
84. Webber, M. M., Bello, D., Kleinman, H. K., Wartinger, D. D. et al., Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 1996, 17, 1641-1646.
85. Webber, M. M., Quader, S. T., Kleinman, H. K., Bello-DeOcampo, D. et al., Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 2001, 1, 1-13.
86. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P. et al., LNCaP model of human prostatic carcinoma. Cancer Res. 1983, 43, 1809-1818.
87. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F. et al., Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979, 17, 16-23.
88. Pfaffl, M. W., Horgan, G. W., Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30, e36.
89. Zhu, W., Depamphilis, M. L., Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 2009, 69, 4870-4877.
90. Salabat, M. R., Melstrom, L. G., Strouch, M. J., Ding, X. Z. et al., Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Mol. Carcinog. 2008, 47, 835-844.
91. Petropoulou, C., Kotantaki, P., Karamitros, D., Taraviras, S., Cdt1 and geminin in cancer: markers or triggers of malignant transformation? Front Biosci. 2008, 1, 4485-4494.
92. Dudderidge, T. J., McCracken, S.R., Loddo, M., Fanshawe, T. R. et al., Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Br. J. Cancer 2007, 96, 1384-1393.
93. Fujita, M., Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells. Cell Div. 2006, 1, 22.